Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.
Also called NCT02831361
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 290 participants
- Sponsor
- Registry
-
NCT02831361
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02831361. Randomized; double masking; primary purpose treatment. Start 2016-10-17 (actual); primary completion 2018-02-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Gemigliptin
- Intervention (Drug)
- Gemigliptin placebo
- Intervention (Drug)
- Metformin
- Intervention (Procedure)
- Diet/exercise questionnaire
- Lead sponsor
- LG Life Sciences
Record details
- Record id
cardio:ct-nct02831361- Content hash
7dea750c085b67c5d6bd5a6afe3d9b775005b804409930385f1cb6f664ba2d6d